Ryan N. Henderson

Array ( [id] => 5010469 [patent_doc_number] => 20070280948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-06 [patent_title] => 'Mammary stem cell marker' [patent_app_type] => utility [patent_app_number] => 11/807937 [patent_app_country] => US [patent_app_date] => 2007-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16586 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20070280948.pdf [firstpage_image] =>[orig_patent_app_number] => 11807937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8796641 [patent_doc_number] => 08435508 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-07 [patent_title] => 'Cloned defective interfering influenza A virus' [patent_app_type] => utility [patent_app_number] => 12/302194 [patent_app_country] => US [patent_app_date] => 2007-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 22266 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12302194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5574987 [patent_doc_number] => 20090142348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Novel Gene Disruptions, Compositions and Methods Relating Thereto' [patent_app_type] => utility [patent_app_number] => 11/814606 [patent_app_country] => US [patent_app_date] => 2007-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 75736 [patent_no_of_claims] => 141 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142348.pdf [firstpage_image] =>[orig_patent_app_number] => 11814606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 52784 [patent_doc_number] => 07771995 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-10 [patent_title] => 'Plasmid encoding human BMP-7' [patent_app_type] => utility [patent_app_number] => 11/803991 [patent_app_country] => US [patent_app_date] => 2007-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 24138 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/771/07771995.pdf [firstpage_image] =>[orig_patent_app_number] => 11803991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5047775 [patent_doc_number] => 20070266449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'GENERATION OF ANIMAL MODELS' [patent_app_type] => utility [patent_app_number] => 11/748046 [patent_app_country] => US [patent_app_date] => 2007-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6783 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20070266449.pdf [firstpage_image] =>[orig_patent_app_number] => 11748046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5509083 [patent_doc_number] => 20090082290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'Intra-vascular kidney gene therapy with plasmid encoding BMP-7' [patent_app_type] => utility [patent_app_number] => 11/801798 [patent_app_country] => US [patent_app_date] => 2007-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 24081 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20090082290.pdf [firstpage_image] =>[orig_patent_app_number] => 11801798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4820306 [patent_doc_number] => 20080226599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Methods of treatment involving p21/CIP1' [patent_app_type] => utility [patent_app_number] => 11/799353 [patent_app_country] => US [patent_app_date] => 2007-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11662 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20080226599.pdf [firstpage_image] =>[orig_patent_app_number] => 11799353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6307568 [patent_doc_number] => 20100069467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'DOUBLE-STRANDED/SELF-COMPLEMENTARY VECTORS WITH A TRUNCATED CBA PROMOTER AND METHODS OF GENE DELIVERY' [patent_app_type] => utility [patent_app_number] => 12/298845 [patent_app_country] => US [patent_app_date] => 2007-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12027 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20100069467.pdf [firstpage_image] =>[orig_patent_app_number] => 12298845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4688133 [patent_doc_number] => 20080032314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => 'Use of VEGF and homologuest to treat neuron disorders' [patent_app_type] => utility [patent_app_number] => 11/789703 [patent_app_country] => US [patent_app_date] => 2007-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14375 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20080032314.pdf [firstpage_image] =>[orig_patent_app_number] => 11789703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 169201 [patent_doc_number] => 07667090 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-23 [patent_title] => 'Transgenic mouse model of B cell malignancy' [patent_app_type] => utility [patent_app_number] => 12/298221 [patent_app_country] => US [patent_app_date] => 2007-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 23 [patent_no_of_words] => 15079 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/667/07667090.pdf [firstpage_image] =>[orig_patent_app_number] => 12298221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 307102 [patent_doc_number] => 07531167 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-12 [patent_title] => 'Herpes simplex virus vector' [patent_app_type] => utility [patent_app_number] => 11/694118 [patent_app_country] => US [patent_app_date] => 2007-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 14 [patent_no_of_words] => 12869 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/531/07531167.pdf [firstpage_image] =>[orig_patent_app_number] => 11694118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7691475 [patent_doc_number] => 20070232558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING PROSTATE CANCER USING DNA VACCINES DIRECTED TO CANCER TESTIS ANTIGEN' [patent_app_type] => utility [patent_app_number] => 11/693856 [patent_app_country] => US [patent_app_date] => 2007-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11638 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20070232558.pdf [firstpage_image] =>[orig_patent_app_number] => 11693856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6517632 [patent_doc_number] => 20100202966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'Implantable Sensor' [patent_app_type] => utility [patent_app_number] => 12/225749 [patent_app_country] => US [patent_app_date] => 2007-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10002 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20100202966.pdf [firstpage_image] =>[orig_patent_app_number] => 12225749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5212357 [patent_doc_number] => 20070250941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'VEGF Receptor Conditional Knockout Animals and Methods of Use' [patent_app_type] => utility [patent_app_number] => 11/691469 [patent_app_country] => US [patent_app_date] => 2007-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18402 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20070250941.pdf [firstpage_image] =>[orig_patent_app_number] => 11691469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374228 [patent_doc_number] => 20090311789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'METHOD FOR PREPARING DIFFERENTIATED AVIAN CELLS AND GENES INVOLVED IN MAINTAINING PLURIPOTENCY' [patent_app_type] => utility [patent_app_number] => 12/294030 [patent_app_country] => US [patent_app_date] => 2007-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10190 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20090311789.pdf [firstpage_image] =>[orig_patent_app_number] => 12294030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8591711 [patent_doc_number] => 08349586 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-01-08 [patent_title] => 'Commensal strain of E. coli encoding an HIV GP41 protein' [patent_app_type] => utility [patent_app_number] => 11/710512 [patent_app_country] => US [patent_app_date] => 2007-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 14132 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11710512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5063603 [patent_doc_number] => 20070225243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor' [patent_app_type] => utility [patent_app_number] => 11/709868 [patent_app_country] => US [patent_app_date] => 2007-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 49163 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20070225243.pdf [firstpage_image] =>[orig_patent_app_number] => 11709868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4758881 [patent_doc_number] => 20080311107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Novel Gene Disruptions, Compositions and Methods Relating Thereto' [patent_app_type] => utility [patent_app_number] => 11/814136 [patent_app_country] => US [patent_app_date] => 2007-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 102 [patent_figures_cnt] => 102 [patent_no_of_words] => 198472 [patent_no_of_claims] => 141 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20080311107.pdf [firstpage_image] =>[orig_patent_app_number] => 11814136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 917867 [patent_doc_number] => 07323617 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-29 [patent_title] => 'Tie-2 driven overexpression of calreticulin as an inducer of non-small cell carcinoma of lung' [patent_app_type] => utility [patent_app_number] => 11/671058 [patent_app_country] => US [patent_app_date] => 2007-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 7062 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/323/07323617.pdf [firstpage_image] =>[orig_patent_app_number] => 11671058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5376148 [patent_doc_number] => 20090313709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'Genetically Modified Animal and Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/223355 [patent_app_country] => US [patent_app_date] => 2007-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 23848 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0313/20090313709.pdf [firstpage_image] =>[orig_patent_app_number] => 12223355 [rel_patent_id] =>[rel_patent_doc_number] =>)